During the four weeks since its IPO, Lemonade has seen its share price soar before falling more than 30 percent from its peak while observers suggest any investor disappointment over the longer term could hurt other insurtechs hoping to go public.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: